About the Authors
- Konstantin Okonechnikov
-
Current Address: Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany
Affiliation Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany
- Aki Imai-Matsushima
-
Affiliation Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany
- Lukas Paul
-
Affiliation Lexogen GmbH, Campus Vienna Biocenter 5, Vienna, Austria
- Alexander Seitz
-
Affiliation Lexogen GmbH, Campus Vienna Biocenter 5, Vienna, Austria
- Thomas F. Meyer
-
* E-mail: fernando.garcia-alcalde@roche.com (FGA); meyer@mpiib-berlin.mpg.de (TFM)
Affiliation Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany
- Fernando Garcia-Alcalde
-
* E-mail: fernando.garcia-alcalde@roche.com (FGA); meyer@mpiib-berlin.mpg.de (TFM)
Current Address: Roche Pharma Research and Early Development, Immunology, Inflammation and Infectious Diseases, Roche Innovation Center Basel, Switzerland
Affiliation Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany
Competing Interests
LP is an employee of Lexogen GmbH, and AS is the founder of Lexogen and owns shares in the company. A patent application (WO2013038010) was filed by Lexogen for the SENSE mRNA-Seq library preparation method and kit. For this study, RNA was extracted and mRNASeq libraries were prepared at Lexogen, and the company funded the NGS run. Lexogen imposes no kind of restriction on the sharing of data and materials. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: KO TFM FGA. Data curation: KO FGA. Formal analysis: KO FGA. Investigation: KO AIM FGA. Methodology: KO FGA. Resources: TFM LP AS. Software: KO FGA. Supervision: TFM FGA. Validation: KO FGA AIM. Visualization: KO. Writing – original draft: KO FGA. Writing – review & editing: KO FGA LP AS TFM.